China Resources Medical Holdings Company Limited

SEHK:1515 주식 보고서

시가총액: HK$5.3b

China Resources Medical Holdings 관리

관리 기준 확인 0/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Hai Yu

최고 경영자

n/a

총 보상

CEO 급여 비율n/a
CEO 임기1.8yrs
CEO 소유권n/a
경영진 평균 재임 기간1.8yrs
이사회 평균 재임 기간2.6yrs

최근 관리 업데이트

Recent updates

Returns At China Resources Medical Holdings (HKG:1515) Appear To Be Weighed Down

Nov 14
Returns At China Resources Medical Holdings (HKG:1515) Appear To Be Weighed Down

Market Participants Recognise China Resources Medical Holdings Company Limited's (HKG:1515) Earnings Pushing Shares 34% Higher

Oct 02
Market Participants Recognise China Resources Medical Holdings Company Limited's (HKG:1515) Earnings Pushing Shares 34% Higher

We Think You Can Look Beyond China Resources Medical Holdings' (HKG:1515) Lackluster Earnings

May 06
We Think You Can Look Beyond China Resources Medical Holdings' (HKG:1515) Lackluster Earnings

China Resources Medical Holdings (HKG:1515) Has A Pretty Healthy Balance Sheet

Apr 26
China Resources Medical Holdings (HKG:1515) Has A Pretty Healthy Balance Sheet

Shareholders Should Be Pleased With China Resources Medical Holdings Company Limited's (HKG:1515) Price

Mar 09
Shareholders Should Be Pleased With China Resources Medical Holdings Company Limited's (HKG:1515) Price

Is China Resources Medical Holdings (HKG:1515) Using Too Much Debt?

Nov 29
Is China Resources Medical Holdings (HKG:1515) Using Too Much Debt?

China Resources Medical Holdings' (HKG:1515) Returns Have Hit A Wall

Oct 19
China Resources Medical Holdings' (HKG:1515) Returns Have Hit A Wall

Analyst Forecasts For China Resources Medical Holdings Company Limited (HKG:1515) Are Surging Higher

Aug 30
Analyst Forecasts For China Resources Medical Holdings Company Limited (HKG:1515) Are Surging Higher

Should You Think About Buying China Resources Medical Holdings Company Limited (HKG:1515) Now?

Aug 26
Should You Think About Buying China Resources Medical Holdings Company Limited (HKG:1515) Now?

China Resources Medical Holdings (HKG:1515) Has A Pretty Healthy Balance Sheet

Jun 30
China Resources Medical Holdings (HKG:1515) Has A Pretty Healthy Balance Sheet

China Resources Medical Holdings (HKG:1515) Will Be Hoping To Turn Its Returns On Capital Around

May 12
China Resources Medical Holdings (HKG:1515) Will Be Hoping To Turn Its Returns On Capital Around

Analysts Just Published A Bright New Outlook For China Resources Medical Holdings Company Limited's (HKG:1515)

Apr 03
Analysts Just Published A Bright New Outlook For China Resources Medical Holdings Company Limited's (HKG:1515)

Is It Too Late To Consider Buying China Resources Medical Holdings Company Limited (HKG:1515)?

Feb 21
Is It Too Late To Consider Buying China Resources Medical Holdings Company Limited (HKG:1515)?

China Resources Medical Holdings (HKG:1515) May Have Issues Allocating Its Capital

Jan 10
China Resources Medical Holdings (HKG:1515) May Have Issues Allocating Its Capital

We Think China Resources Medical Holdings (HKG:1515) Can Manage Its Debt With Ease

Nov 30
We Think China Resources Medical Holdings (HKG:1515) Can Manage Its Debt With Ease

Is China Resources Medical Holdings Company Limited (HKG:1515) Trading At A 23% Discount?

Oct 18
Is China Resources Medical Holdings Company Limited (HKG:1515) Trading At A 23% Discount?

China Resources Medical Holdings (HKG:1515) Will Want To Turn Around Its Return Trends

Sep 21
China Resources Medical Holdings (HKG:1515) Will Want To Turn Around Its Return Trends

Are Investors Undervaluing China Resources Medical Holdings Company Limited (HKG:1515) By 47%?

Jul 13
Are Investors Undervaluing China Resources Medical Holdings Company Limited (HKG:1515) By 47%?

Is It Time To Consider Buying China Resources Medical Holdings Company Limited (HKG:1515)?

Jun 24
Is It Time To Consider Buying China Resources Medical Holdings Company Limited (HKG:1515)?

China Resources Medical Holdings (HKG:1515) Is Increasing Its Dividend To HK$0.12

Jun 03
China Resources Medical Holdings (HKG:1515) Is Increasing Its Dividend To HK$0.12

China Resources Medical Holdings (HKG:1515) Will Pay A Larger Dividend Than Last Year At HK$0.12

Apr 27
China Resources Medical Holdings (HKG:1515) Will Pay A Larger Dividend Than Last Year At HK$0.12

We Think China Resources Medical Holdings (HKG:1515) Can Manage Its Debt With Ease

Apr 22
We Think China Resources Medical Holdings (HKG:1515) Can Manage Its Debt With Ease

Growth Investors: Industry Analysts Just Upgraded Their China Resources Medical Holdings Company Limited (HKG:1515) Revenue Forecasts By 45%

Mar 30
Growth Investors: Industry Analysts Just Upgraded Their China Resources Medical Holdings Company Limited (HKG:1515) Revenue Forecasts By 45%

Is Now An Opportune Moment To Examine China Resources Medical Holdings Company Limited (HKG:1515)?

Jan 27
Is Now An Opportune Moment To Examine China Resources Medical Holdings Company Limited (HKG:1515)?

China Resources Medical Holdings Company Limited (HKG:1515) Shares Could Be 37% Below Their Intrinsic Value Estimate

Jan 03
China Resources Medical Holdings Company Limited (HKG:1515) Shares Could Be 37% Below Their Intrinsic Value Estimate

China Resources Medical Holdings (HKG:1515) Will Be Hoping To Turn Its Returns On Capital Around

Nov 19
China Resources Medical Holdings (HKG:1515) Will Be Hoping To Turn Its Returns On Capital Around

Is It Too Late To Consider Buying China Resources Medical Holdings Company Limited (HKG:1515)?

Oct 26
Is It Too Late To Consider Buying China Resources Medical Holdings Company Limited (HKG:1515)?

An Intrinsic Calculation For China Resources Medical Holdings Company Limited (HKG:1515) Suggests It's 44% Undervalued

Sep 20
An Intrinsic Calculation For China Resources Medical Holdings Company Limited (HKG:1515) Suggests It's 44% Undervalued

Here's Why China Resources Medical Holdings (HKG:1515) Can Manage Its Debt Responsibly

Sep 06
Here's Why China Resources Medical Holdings (HKG:1515) Can Manage Its Debt Responsibly

China Resources Medical Holdings (HKG:1515) Might Be Having Difficulty Using Its Capital Effectively

Aug 17
China Resources Medical Holdings (HKG:1515) Might Be Having Difficulty Using Its Capital Effectively

Broker Revenue Forecasts For China Resources Medical Holdings Company Limited (HKG:1515) Are Surging Higher

Jun 21
Broker Revenue Forecasts For China Resources Medical Holdings Company Limited (HKG:1515) Are Surging Higher

China Resources Medical Holdings Company Limited (HKG:1515) Shares Could Be 34% Below Their Intrinsic Value Estimate

Jun 09
China Resources Medical Holdings Company Limited (HKG:1515) Shares Could Be 34% Below Their Intrinsic Value Estimate

Investors Can Find Comfort In China Resources Medical Holdings' (HKG:1515) Earnings Quality

May 03
Investors Can Find Comfort In China Resources Medical Holdings' (HKG:1515) Earnings Quality

China Resources Medical Holdings Company Limited (HKG:1515) Is Yielding 1.4% - But Is It A Buy?

Apr 22
China Resources Medical Holdings Company Limited (HKG:1515) Is Yielding 1.4% - But Is It A Buy?

We Think China Resources Medical Holdings (HKG:1515) Can Stay On Top Of Its Debt

Mar 27
We Think China Resources Medical Holdings (HKG:1515) Can Stay On Top Of Its Debt

CEO

Hai Yu (56 yo)

1.8yrs

테뉴어

Mr. Hai Yu is Chief Executive Officer & Executive Director of China Resources Medical Holdings Company Limited from February 27, 2023. He is the general manager of China Resources Health Group Limited, and...


리더십 팀

이름위치테뉴어보상소유권
Baojie Shan
VP & Executive Director3yrsCN¥3.24m데이터 없음
Qing Song
Executive Chairman of the Board6.3yrsCN¥71.00k0.031%
HK$ 1.6m
Hai Yu
CEO & Executive Director1.8yrs데이터 없음데이터 없음
Min Yang
CFO & Executive Director1.5yrs데이터 없음데이터 없음
Ming Fai Chung
Company Secretaryless than a year데이터 없음데이터 없음

1.8yrs

평균 재임 기간

53yo

평균 연령

경험이 풍부한 관리: 1515 의 관리팀은 경험 (평균 재직 기간 1.8 년)으로 간주되지 않으므로 새로운 팀을 추천합니다.


이사회 구성원

이름위치테뉴어보상소유권
Baojie Shan
VP & Executive Director3.3yrsCN¥3.24m데이터 없음
Qing Song
Executive Chairman of the Board6.3yrsCN¥71.00k0.031%
HK$ 1.6m
Hai Yu
CEO & Executive Director1.8yrs데이터 없음데이터 없음
Min Yang
CFO & Executive Director1.5yrs데이터 없음데이터 없음
Yuning Fu
Honorary Chairman8.1yrs데이터 없음데이터 없음
Tingmei Fu
Independent Non-Executive Director1.8yrs데이터 없음데이터 없음
Ting Yuk Wu
Independent Non-Executive Director6.3yrsCN¥257.00k데이터 없음
Kwok Kong Kwong
Independent Non-Executive Director11.3yrsCN¥257.00k데이터 없음
Lu Ge
Non-Executive Director1.3yrs데이터 없음0.0051%
HK$ 267.3k
Peng Zhou
Independent Non-Executive Director1.3yrsCN¥81.00k데이터 없음

2.6yrs

평균 재임 기간

57yo

평균 연령

경험이 풍부한 이사회: 1515 의 이사회경험(평균 재직 기간 2.6 년)으로 간주되지 않으므로 새 이사회가 필요합니다.


기업 분석 및 재무 데이터 현황

데이터마지막 업데이트(UTC 시간)
기업 분석2024/12/28 22:03
장 마감 주가2024/12/27 00:00
수익2024/06/30
연간 수익2023/12/31

데이터 소스

기업 분석에 사용된 데이터는 S&P Global Market Intelligence LLC의 데이터입니다. 이 보고서를 생성하기 위해 분석 모델에 사용된 데이터는 다음과 같습니다. 데이터는 정규화되어 있으므로 소스가 제공되기까지 지연이 발생할 수 있습니다.

패키지데이터기간미국 소스 예시 *
회사 재무10년
  • 손익 계산서
  • 현금 흐름표
  • 대차 대조표
애널리스트 컨센서스 추정치+3년
  • 재무 예측
  • 애널리스트 목표가
시장 가격30년
  • 주식 가격
  • 배당금, 분할 및 액션
소유권10년
  • 최대 주주
  • 내부자 거래
관리10년
  • 리더십 팀
  • 이사회
주요 개발 사항10년
  • 회사 공지 사항

* 미국 증권의 경우, 미국 외 지역의 규제 양식 및 출처가 사용된 예입니다.

명시되지 않는 한 모든 재무 데이터는 1년을 기준으로 하지만 분기별로 업데이트됩니다. 이를 후행 12개월(TTM) 또는 최근 12개월(LTM) 데이터라고 합니다. 여기에서 자세히 알아보세요.

분석 모델 및 눈송이

이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 Github 페이지에서 확인할 수 있으며, 보고서 사용 방법에 대한 가이드와 튜토리얼도 유튜브에서 확인할 수 있습니다.

Simply 월스트리트 분석 모델을 설계하고 구축한 세계적인 수준의 팀에 대해 알아보세요.

산업 및 부문 메트릭

업계 및 섹션 지표는 Simply Wall St에서 6시간마다 계산되며, 자세한 내용은 확인할 수 있습니다.

애널리스트 출처

China Resources Medical Holdings Company Limited 27 애널리스트 중 6 애널리스트가 보고서의 입력 자료로 사용된 매출 또는 수익 추정치를 제출했습니다. 애널리스트의 제출 자료는 하루 종일 업데이트됩니다.

분석가교육기관
Ling ZhangBNP Paribas Securities (Asia)
Yue-Kwong LuiBOCOM International Securities Limited
Jessica LiBofA Global Research